MitchelLFrommMD

Radiation Oncology • Akron, OH

Physician

Join to view full profile

Dr. Fromm is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fromm's full profile

Already have an account?

Office
1 Akron General Ave
Akron, OH 44307
Phone+1 330-384-6448

Fax+1 330-344-6512

Education & Training

University of Pennsylvania Health SystemResidency, Radiation Oncology, 1982 - 1984
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1972 - 1975
Perelman School of Medicine at the University of PennsylvaniaClass of 1972

Certifications & Licensure

OH State Medical License 1986 - 2027
IL State Medical License 2022 - 2023
PA State Medical License 1973 - 1992
American Board of Pediatrics Pediatrics
American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

Northern Ohio Live Castle Connolly, 2006-2009

Clinical Trials

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
ACTIVE_NOT_RECRUITING
PHASE3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
ACTIVE_NOT_RECRUITING
PHASE3
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer Start of enrollment: 2012 Dec 06
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

8 citations
Pure embryonal rhabdomyosarcoma of the fallopian tube
Cheryl L. Buchwalter, Eric L. Jenison, Mitchell Fromm, V.T. Mehta, William R. Hart
Gynecologic Oncology. 1997-10-01

Press Mentions

Cleveland Clinic Akron General Invests $6 Million in Machines for Radiation TherapyMay 30th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member